Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Update

Takara Bio Inc. (OTCMKTS:TKBIF) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 17,400 shares, an increase of 21.7% from the December 31st total of 14,300 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Takara Bio Price Performance

Shares of TKBIF remained flat at $23.20 during mid-day trading on Friday. The firm’s 50-day moving average is $23.20 and its 200 day moving average is $23.20. Takara Bio has a 52-week low of $23.20 and a 52-week high of $23.20.

Takara Bio Company Profile

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.